[{"Assets_0_Q2_USD":267081000.0,"CommonStockSharesOutstanding_0_Q2_shares":65154729.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-76263000.0,"NetIncomeLoss_1_Q2_USD":-42713000.0,"NetIncomeLoss_2_Q2_USD":-82385000.0,"StockholdersEquity_0_Q2_USD":10588000.0,"Ticker":"DVAX","CIK":"1029142","name":"DYNAVAX TECHNOLOGIES CORP","OfficialName":"Dynavax Technologies Corporation Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1279198792.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]